311 related articles for article (PubMed ID: 2871107)
1. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness.
Rook AH; Kehrl JH; Wakefield LM; Roberts AB; Sporn MB; Burlington DB; Lane HC; Fauci AS
J Immunol; 1986 May; 136(10):3916-20. PubMed ID: 2871107
[TBL] [Abstract][Full Text] [Related]
2. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction.
Ortaldo JR; Mason AT; O'Shea JJ; Smyth MJ; Falk LA; Kennedy IC; Longo DL; Ruscetti FW
J Immunol; 1991 Jun; 146(11):3791-8. PubMed ID: 1851793
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
[TBL] [Abstract][Full Text] [Related]
5. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
Mandler RN; Biddison WE; Mandler R; Serrate SA
J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
[TBL] [Abstract][Full Text] [Related]
6. Effect of cortisol on the native and in vitro induced non-MHC restricted cytotoxicity of large granular lymphocytes.
Matera L; Cardoso E; Veglia F; Cesano A; Bellone G; Vuolo A; Molinatti GM
J Clin Lab Immunol; 1988 Oct; 27(2):77-81. PubMed ID: 3266762
[TBL] [Abstract][Full Text] [Related]
7. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
Espevik T; Figari IS; Ranges GE; Palladino MA
J Immunol; 1988 Apr; 140(7):2312-6. PubMed ID: 3280680
[TBL] [Abstract][Full Text] [Related]
9. Regulation of NK cell functions by TGF-beta 1.
Bellone G; Aste-Amezaga M; Trinchieri G; Rodeck U
J Immunol; 1995 Aug; 155(3):1066-73. PubMed ID: 7636180
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
11. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye.
Apte RS; Niederkorn JY
J Immunol; 1996 Apr; 156(8):2667-73. PubMed ID: 8609381
[TBL] [Abstract][Full Text] [Related]
14. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
15. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.
Gray JD; Hirokawa M; Ohtsuka K; Horwitz DA
J Immunol; 1998 Mar; 160(5):2248-54. PubMed ID: 9498764
[TBL] [Abstract][Full Text] [Related]
16. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
Saito S; Morii T; Enomoto M; Sakakura S; Nishikawa K; Narita N; Ichijo M
Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983
[TBL] [Abstract][Full Text] [Related]
17. Effect of phorbol esters on the activity of purified transforming growth factors.
Kraft AS
Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
[TBL] [Abstract][Full Text] [Related]
18. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
[TBL] [Abstract][Full Text] [Related]
19. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
[TBL] [Abstract][Full Text] [Related]
20. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
